Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 2010 Oct 22;89(2):121–126. doi: 10.2471/BLT.09.075002

Endemic goitre in the Sudan despite long-standing programmes for the control of iodine deficiency disorders

الدُراق المتوطن في السودان على الرغم من البرامج الطويلة الأمد لمكافحة اضطرابات عوز اليود

Goitre endémique au Soudan malgré les programmes permanents de contrôle des troubles dus à la carence en iode

Persistencia del bocio endémico en Sudán pese a la aplicación desde hace tiempo de programas para controlar los trastornos por deficiencia de yodo

Распространенность эндемического зоба в Судане, несмотря на осуществление долгосрочных программ борьбы с нарушениями, обусловленными йодной недостаточностью

苏丹长期碘缺乏症控制计划下的地方性甲状腺肿

Abdel Monim MH Medani a,, Abdelsalam A Elnour b, Amal M Saeed c
PMCID: PMC3040373  PMID: 21346923

Abstract

Objective

To describe the status of iodine deficiency disorders (IDDs) in the Sudan more than 25 years after the initiation of IDD control programmes and to explore the causes of endemic goitre in the country.

Methods

Testing for IDDs was carried out in 6083 schoolchildren 6 to 12 years of age from the capital cities of nine states in different areas of the country using the three indicators recommended by the World Health Organization: the prevalence of goitre, laboratory measurements of urinary iodine concentration in casual urine samples and serum thyroglobulin (Tg) levels. Serum levels of thyroxine (T4), triiodothyronine (T3) and thyroid-stimulating hormone (TSH), as well as urinary secretion of thiocyanate, which can affect the transport of iodine into thyrocytes, were also measured.

Findings

The prevalence of goitre in the different samples ranged from 12.2% to 77.7% and was 38.8% overall. The overall median urinary iodine concentration was 6.55 μg/dl, with the lowest median value having been found in Kosti city (2.7 μg/dl), situated in the centre of the country, and the highest (46.4 μg/dl) in Port Sudan, on the Red Sea coast. The highest mean serum Tg level (66.98 ng/ml) was found in Kosti city, which also had the highest prevalence of goitre.

Conclusion

IDDs still constitute a public health problem throughout urban areas in the Sudan and iodine deficiency appears to be the main etiological factor involved.

Introduction

In the Sudan, the period from the early 1980s to the mid 1990s witnessed substantial activity in connection with iodine deficiency disorders (IDDs) in the form of epidemiological and etiological studies and assessments of the effects of different interventions.17 The total prevalence of goitre reported in those studies ranged from 13% in the eastern city of Port Sudan and 17% in Khartoum state, to 78% in the central region and 87% in Darfur, in the west. According to a national study conducted in 1997, the overall prevalence of all types of goitre was 22%8 and prevalence figures ranged from 5% in the city of Khartoum to 42% in the Upper Nile region. It has been estimated that every year more than 200 000 children born in the Sudan are at risk of iodine deficiency9 and that 3% of those children may develop cretinism, while 10% may experience severe intellectual impairment and 87% less severe intellectual disability.

Various etiological factors in addition to iodine deficiency contribute to goitre endemicity in the Sudan.13,5,7 They include vitamin A deficiency and protein-energy malnutrition, both of which can affect thyroid function, and the very high consumption of pearl millet, which contains thiocyanate, a goitrogenic substance.

Although IDD control programmes in the form of distribution of iodized oil capsules and iodized sugar and the universal salt iodization strategy, were launched in the Sudan as early as the mid 1970s,5,10,11 in 2006, when this study was conducted, no progress in implementation had been made.9 Indeed, most iodine supplementation programmes, if not all, had ceased to exist, and only 1% of all Sudanese households had access to iodized salt, according to estimates by the United Nations Children’s Fund (UNICEF).12 A more recent situational analysis has shown that IDDs still affect children and women throughout the Sudan and that no policy supporting universal salt iodization is in place.13 Thus, the aim of this study is to evaluate the current status of IDDs in the Sudan and to provide baseline impact indicators for future IDD control programmes. The study also seeks to respond to the 2005 World Health Assembly resolution (WHA58.24) mandating countries to report on their IDD situation every three years.

Methods

We performed a descriptive cross-sectional study to investigate the burden of IDDs using three indicators recommended by the World Health Organization (WHO): goitre prevalence, median urinary iodine concentration (UIC) (determined from casual urine samples) and mean serum thyroglobulin (Tg) levels. Mean serum levels of thyroxine (T4), triiodothyronine (T3) and thyroid-stimulating hormone (TSH) were also measured, along with urinary thiocyanate (USCN) excretion.13,9,10 Our study, which was conducted from June to November 2006, covered ethnically and socioeconomically heterogeneous populations of schoolchildren aged 6 to 12 years residing in the capital cities of nine states located in different parts of the Sudan. The cities were Nyala (west), Elfasir (west), Wau (south), Atbra and Dongla (north), Kosti (centre), Dmazine (south-east), Port Sudan (east) and Khartoum (centre). The sampled populations varied considerably with respect to their sources of drinking water and their staple foods. The locations from which population samples were drawn are shown on the map of the Sudan in Fig. 1.

Fig. 1.

Fig. 1

Map of the Sudan showing cities included in study of iodine status among schoolchildren aged 6 to 12 years in the country, June–November 2006

A multistage sampling technique was used.14 Each city was first divided into three sectors and one school from each sector was then randomly selected, regardless of the gender of the school’s attendees. Subsequently 150 to 250 children were randomly selected from each school and a total of 6083 children between the ages of 6 and 12 years were examined for goitre by a single investigator through palpation of the thyroid gland. Goitre size was graded according to the criteria recommended by WHO, UNICEF and the International Council for the Control of Iodine Deficiency Disorders (grade 0, no goitre; grade 1, thyroid palpable but not visible; and grade 2, thyroid visible with neck in normal position) .15 The combined prevalence of grade 1 and 2 goitre provided the total prevalence of goitre in the study population. In this study, the endemicity of goitre was classified on the basis of median urinary iodine excretion as established for schoolchildren by WHO.16 < 2.0 µg/dl, severe iodine deficiency; 2.0–4.9 µg/dl, moderate iodine deficiency; 5.0–9.9 µg/dl, mild iodine deficiency.

Blood and urine samples were collected from 360 children who were chosen by systematic random sampling, irrespective of gender or of the results of thyroid gland palpation. Serum samples were analysed for T4, T3, TSH and Tg using radioimmunoassay with reagents obtained from the Department of Isotopes of the China Institute for Atomic Energy in Beijing. Urine samples were used for two purposes: a fresh portion was used to determine the urinary iodine concentration and a portion that was kept at −20 °C for 5 months was used to measure USCN excretion. The UIC was measured using a modified Sandell-Kothoff reaction.17 USCN excretion was measured by the method described by Aldridge18 as modified by Michajlovskij & Langer.19 Blood and urine samples were analysed in the laboratories of the Sudan Atomic Energy Commission. Statistical analysis was performed using SPSS version 13.0 (SPSS Inc., Chicago, United States of America). The central tendency was described by the arithmetic and geometric mean in the case of serum levels and by the median in the case of urine levels. Linear regression was used to explore the relationship between variables (goitre prevalence, T3 and T4, Tg, UIC and USCN). The χ2 test was used to test for differences in proportions (goitre prevalence) and the differences among all pairs of proportions were determined by the Marascuilo procedure. One-way analysis of variance was used to explore differences in mean serum T4, T3, TSH and Tg levels in the nine study cities. The procedure of least significant difference was applied to look for differences among pairs of means. Significance was set at P < 0.05.

The present study was approved by the review board of the Sudanese Academy of Sciences, and consent was obtained from local health and education authorities and from the department of school nutrition of the Ministry of Education. Permission for collecting blood and urine samples was verbally obtained from one of the parents of each pupil through school headmasters and parent councils. Pupils who declined to participate were randomly substituted with other students from the same classroom.

Results

The prevalence of all types of goitre is shown in Table 1. It was found to be 38.8% overall and ranged from 12.2% in Omdurman to 77.7% in Kosti city.

Table 1. Goitre prevalence (GP) in schoolchildren aged 6 to 12 years from selected cities in the Sudan, June–November 2006.

City No. of children
GP (%)
With goitre Without goitre Total
Wau 255 261 516 49.4
Elfasir 435 224 659 66.0
Nyala 307 172 479 64.1
Dmazine 140 382 522 26.9
Kosti 407 117 524 77.7
Atbra 150 495 645 23.3
Khartoum 71 426 497 14.3
Khartoum north 89 430 519 17.2
Omdurman 72 517 589 12.2
Dongla 207 272 479 43.2
Port Sudan 228 426 654 34.9
Total 2361 3722 6083 38.8

Median UIC and median USCN excretion are presented in Table 2. The overall median urinary iodine concentration was 6.55 µg/dl, which is indicative of mild iodine deficiency, and 35% of the population had < 5 µg/dl. The median local urinary iodine concentration was < 10µg/dl in all cities with the exception of Port Sudan. It was lowest in Kosti, where goitre was most prevalent, and highest in Port Sudan. Median USCN excretion ranged from 0.26 mg/dl in Port Sudan to 0.49 mg/dl in Wau and Nyala. The overall median value was 0.37 mg/dl.

Table 2. Goitre prevalence (GP) and other clinical indicators of thyroid functiona and iodine statusb in schoolchildren aged 6 to 12 years from selected cities in the Sudan, June–November 2006.

City GP
T4 (nmol/l)
T3 (nmol/l)
TSH (mIU/l)
Tg (ng/ml)
UIC (µg/dl)
USCN (mg/dl)
% Mean SE Mean SE Mean SE Mean SE Median Median
Nyala 64.1 112.8 4.00 1.90 0.07 1.83 0.18 22.83 1.99 6.15 0.48
Elfasir 66.0 110.1 3.40 1.70 0.06 1.73 0.15 28.31 1.89 3.35 0.45
Dmazine 26.9 104.6 4.40 1.97 0.07 2.71 0.24 30.98 3.75 7.30 0.41
Wau 49.2 112.4 5.60 2.22 0.12 1.69 0.14 25.71 2.52 9.40 0.49
Atbra 23.3 108.7 4.40 1.85 0.10 2.42 0.18 40.47 2.30 2.80 0.40
Kosti 77.7 110.4 4.70 1.74 0.07 1.78 0.19 66.98 4.47 2.70 0.35
Khartoum 14.3 101.0 5.60 2.13 0.08 1.71 0.15 56.33 2.83 5.80 0.32
Khartoum north 17.2 96.8 4.50 2.19 0.07 2.18 0.31 38.45 3.81 7.00 0.37
Omdurman 12.2 105.3 5.20 2.19 0.06 1.95 0.15 37.99 3.97 6.85 0.34
Dongla 43.2 87.4 4.10 1.83 0.09 3.13 0.32 27.22 1.82 8.90 0.31
Port Sudan 34.9 82.6 5.00 1.54 0.09 3.71 0.56 46.02 4.21 46.40 0.26
Overall 38.8 103.2 1.50 1.94 0.03 2.25 0.08 38.00 1.16 6.55 0.37

SE, standard error; T4, thyroxine; Tg, thyroglobulin; T3, triiodothyronine; TSH, thyroid-stimulating hormone; UIC, urinary iodine concentration; USCN, urinary thiocyanate.

a Normal total serum levels of T3, T4, TSH and Tg according to the Sudan Atomic Energy Commission are as follows: T4, 60–165 nmol/l; T3, 0.8–3.0 nmol/l; TSH, 0.7–5.0 mIU/l; Tg, 4.1–24.0 ng/ml.

b For UIC and USCN excretion, 10–20 μg/dl and ≤ 0.9 mg/dl, respectively, were considered normal values.

Table 2 also shows mean serum T4, T3, TSH and Tg levels. The overall mean serum T4 and T3 levels were within the normal range. The mean serum T4 level in Dongla was similar to the mean level found in Port Sudan and lower than the level found in other cities. Mean serum T3 levels also varied widely among cities. Overall, serum Tg values were > 40 ng/ml in more than 40% of the children. No correlation was found between goitre prevalence and mean serum Tg or between goitre prevalence and median urinary iodine concentration (Table 3).

Table 3. Correlation between various clinical indicators of thyroid function and iodine status in study of 360 schoolchildren aged 6 to 12 years from selected cities in the Sudan, June–November 2006.

Indicator Correlation Indicator
T4 T3 TSH Tg UIC USCN GP
T4 ra 1 0.328 −0.174 0.014 −0.201 0.190 0.082
Pb 0.000 0.001 0.786 0.000 0.000 0.122
T3 r 0.328 1 −0.062 0.008 −0.149 0.111 −0.255
P 0.000 0.238 0.875 0.005 0.036 0.000
TSH r −0.174 −0.062 1 0.093 0.301 −0.083 −0.046
P 0.001 0.238 0.078 0.000 0.118 0.384
Tg r 0.014 0.008 0.093 1 0.053 −0.101 −0.006
P 0.786 0.875 0.078 0.315 0.057 0.910
UIC r −0.201 −0.149 0.301 0.053 1 −0.036 0.059
P 0.000 0.005 0.000 0.315 0.491 0.262
USCN r 0.190 0.111 −0.083 −0.101 −0.036 1 0.085
P 0.000 0.036 0.118 0.057 0.491 0.107
GP r 0.082 −0.255 −0.046 −0.006 0.059 0.085 1
P 0.122 0.000 0.384 0.910 0.262 0.107

T3, triiodothyronine; T4, thyroxine; TSH, thyroid-stimulating hormone; Tg, thyroglobulin; UIC, urinary iodine concentration; USCN, urinary thiocyanate.

a Pearson’s correlation coefficient.

b Significance on two-tailed test.

Table 3 shows Pearson's correlation coefficients between the measured variables exploring the relationship and significance levels between variables (goitre prevalence, thyroid hormones, TSH, Tg, UIC and USCN excretion in 360 Sudanese schoolchildren from selected Sudanese cities.

Discussion

WHO recommends using the following physiologic indicators to assess the iodine status of populations beyond the neonatal period: mean urinary iodine concentration (based on measurements in casual urine samples), the prevalence of goitre (based on palpation of the thyroid gland) and mean serum TSH and Tg.20 At the individual level, these physiologic indicators are sensitive to iodine deficiencies of different duration. For example, urinary iodine concentration is a sensitive indicator of recent iodine intake (days), Tg shows an intermediate response (weeks to months), and the size of the thyroid reflects long-term iodine intake (months to years). The overall prevalence of goitre and the median urinary iodine concentration in schoolchildren 6 to 12 years of age are the most accepted markers for assessing the severity of IDDs in a given region.16 In this study, all methods recommended by WHO were employed to assess IDDs in the population of schoolchildren. While the prevalence of goitre puts the Sudan among countries with a severe IDD problem, the median urinary iodine concentration is indicative of a mild IDD problem.21 In the nine cities studied, the prevalence of endemic goitre ranged from mild to severe. A population is considered to have iodine sufficiency when the median urinary iodine concentration is between 10 and 19.9 μg/dl and less than 20% of the people have a concentration < 5 μg/dl.21 Goitre prevalence and urinary iodine concentration showed no correlation with each other (Table 3). In the population studied, goitre prevalence placed the cities in a higher IDD status category than did the median urinary iodine concentration, perhaps because other goitrogenic factors besides insufficient iodine intake may be at play.1,7 Thiocyanate probably played little or no role in the etiology of goitre in this study, since its urinary concentration was much lower than reported in other areas with iodine deficiency.22 Despite the clear lack of correlation between mean serum Tg and goitre prevalence, the highest mean serum Tg was found in Kosti, where goitre prevalence was highest and median urinary iodine concentration was lowest. Although some studies have found serum Tg to be a sensitive indicator of chronic and acute thyroid stimulation,23,24 other studies have shown that serum Tg may be affected by other factors.25,26 This may explain why mean serum Tg in children from Khartoum was rather high despite the relatively low prevalence of goitre.

The exceptionally high median urinary iodine concentration (46.40 µg/dl) in Port Sudan is well above the level (30 µg/dl) indicative of a high individual risk of iodine-induced hyperthyroidism and, in genetically susceptible individuals, of autoimmune thyroid disease from excess iodine intake.27 However, in this city mean serum T4 and T3 levels were lower and the mean TSH level was higher than in other cities, as noted earlier by Eltom28 and recently by Hussein.29 The high median urinary iodine concentration in Port Sudan could be attributed to the consumption of seafood rich in iodine, since the city is located on the coast of the Red Sea. It is noteworthy that the city of Atbra was not studied before, since its location between Khartoum and Port Sudan and between Khartoum and the northern states leads one to expect a diversified diet. However, the median urinary iodine concentration in Atbra was 2.8 µg/dl and only 5 pupils out of 35 had sufficient (10 µg/dl) urinary iodine concentration. This supports previous findings that goitre may be spreading to new areas of the Sudan.

The results of the current study strongly agree with those of previous studies.57,11,30 Iodine deficiency is probably the most important but not the only factor leading to the high prevalence of goitre in the population studied. Such a population, it may be worth noting, was composed of schoolchildren living in urban areas, who may have had a more diversified diet and one higher in iodine than children living in rural areas. In areas where iodine intake is low, hypothyroidism,31 different degrees of intellectual impairment and even cretinism can sometimes affect a significant proportion of people, even if mean serum T4, T3 and TSH levels are within normal ranges.32

In conclusion, despite the fact that IDD control programmes were initiated in the Sudan more than 25 years ago, IDDs continue to be an important public health problem in the country. Although imported iodized salt is commercially available, no data on its consumption exist. An evaluation of existing IDD control programmes is urgently needed and strong consideration should be given to reinstituting the universal salt iodization programme.

Funding:

This work was funded by the Sudan Atomic Energy Commission.

Competing interests:

None declared. A poster presentation of this study was made at the Micronutrient Forum 2009 Meeting in Beijing, China, and subsequently published at: http://www.micronutrientforum.org/Meeting2009/PDFs/Poster%20Presentations/1_Tuesday/1_Iodine%20and%20Universal%20Salt%20Iodization/TU07_Hassan.pdf

References

  • 1.Osman AK, Fatah AA. Factors other than iodine deficiency contributing to the endemicity of goitre in Darfur Province (Sudan). J Hum Nutr. 1981;35:302–9. doi: 10.3109/09637488109143057. [DOI] [PubMed] [Google Scholar]
  • 2.Osman AK, Basu TK, Dickerson JW. A goitrogenic agent from millet (Pennisetum typhoides) in Darfur Province, western Sudan. Ann Nutr Metab. 1983;27:14–8. doi: 10.1159/000176619. [DOI] [PubMed] [Google Scholar]
  • 3.Eltom M. Endemic goiter in Sudan [dissertation]. Uppsala: Uppsala University; 1993. [Google Scholar]
  • 4.Abdel-Wahab MM, Eltom M, Omer MI, Mukhtar E, Kaballo AM. Prophylaxis and treatment of endemic goitre in western Sudan with intramuscular iodized oil. Ann Trop Paediatr. 1984;4:159–64. doi: 10.1080/02724936.1984.11748327. [DOI] [PubMed] [Google Scholar]
  • 5.Hassan AM. Studies on simple goiter in Omdurman [dissertation]. Khartoum: University of Khartoum; 1993. [Google Scholar]
  • 6.Elnagar B, Eltom M, Karlsson FA, Ermans AM, Gebre-Medhin M, Bourdoux PP. The effects of different doses of oral iodized oil on goiter size, urinary iodine, and thyroid-related hormones. J Clin Endocrinol Metab. 1995;80:891–7. doi: 10.1210/jc.80.3.891. [DOI] [PubMed] [Google Scholar]
  • 7.Elnour A, Hambraeus L, Eltom M, Dramaix M, Bourdoux P. Endemic goiter with iodine sufficiency: a possible role for the consumption of pearl millet in the etiology of endemic goiter. Am J Clin Nutr. 2000;71:59–66. doi: 10.1093/ajcn/71.1.59. [DOI] [PubMed] [Google Scholar]
  • 8.Ministry of Health, Directorate General Primary Health Care, National Nutrition Department. IDD baseline survey report Khartoum: Ministry of Health; 1999. [Google Scholar]
  • 9.Bani I. Accelerating USI progress in Sudan. IDD Newsletter. 2007;24:9–12. [Google Scholar]
  • 10.Eltom M, Monawer L, Kamal AM, Stephen P. Iodated salt intervention strategy in Sudan. Khartoum: United Nations Children’s Fund & Federal Ministry of Health; 1994. [Google Scholar]
  • 11.Eltom M, Salih MA, Boström H, Dahlberg PA. Differences in aetiology and thyroid function in endemic goitre between rural and urban areas of the Darfur region of the Sudan. Acta Endocrinol (Copenh) 1985;108:356–60. doi: 10.1530/acta.0.1080356. [DOI] [PubMed] [Google Scholar]
  • 12.Hussein I. Severe iodine deficiency in Sudan. IDD Newsletter. 2006;24:5–7. [Google Scholar]
  • 13.Izzeldin SH, Crawford MA, Ghebremeskel K. Salt fortification with iodine: Sudan situation analysis. Nutr Health. 2009;20:21–30. doi: 10.1177/026010600902000103. [DOI] [PubMed] [Google Scholar]
  • 14.Kevin M, Robin H, Jonathan G, Jenny C. Monitoring universal salt iodization programs (WHO/ICCIDD/UNICEF/MI manual). Geneva: World Health Organization & United Nations Children’s Fund & International Council for the Control of Iodine Deficiency Disorders; 1995. [Google Scholar]
  • 15.Indicators for assessing iodine deficiency disorders and their control through salt iodization Geneva: World Health Organization & United Nations Children’s Fund & International Council for the Control of Iodine Deficiency Disorders; 1994. [Google Scholar]
  • 16.Assessment of iodine deficiency disorders and monitoring their elimination Geneva: World Health Organization & United Nations Children’s Fund & International Council for the Control of Iodine Deficiency Disorders; 2001. [Google Scholar]
  • 17.Pino S, Fang SL, Braverman LE. Ammonium persulfate: a safe alternative oxidizing reagent for measuring urinary iodine. Clin Chem. 1996;42:239–43. [PubMed] [Google Scholar]
  • 18.Aldridge WN. The estimation of micro quantities of cyanide and thiocyanate. Analyst (Lond) 1945;70:474–5. [PubMed] [Google Scholar]
  • 19.Michajlovskij N, Langer P. [Studies on relations between thiocyanate formation and goitrogenic properties of foods. I. Preformed thiocyanate content of some foods]. Hoppe Seylers Z Physiol Chem. 1958;312:26–30. German. [PubMed] [Google Scholar]
  • 20.Indicators for assessing iodine deficiency disorders and their control through salt iodization Geneva: World Health Organization & United Nations Children’s Fund & International Council for the Control of Iodine Deficiency Disorders; 1994. [Google Scholar]
  • 21.Assessment of iodine deficiency disorders and monitoring their elimination 3rd ed. Geneva: World Health Organization & United Nations Children’s Fund & International Council for the Control of Iodine Deficiency Disorders; 2007. [Google Scholar]
  • 22.Chandra AK, Bhattacharjee A, Malik T, Ghosh S. Etiological factors for the persistence of endemic goiter in selected areas of Siddharthnagar district in Eastern Uttar Pradesh, India. J Pediatr Endocrinol Metab. 2009;22:317–25. doi: 10.1515/jpem.2009.22.4.317. [DOI] [PubMed] [Google Scholar]
  • 23.Pennington JA. A review of iodine toxicity reports. J Am Diet Assoc. 1990;90:1571–81. [PubMed] [Google Scholar]
  • 24.Zimmermann MB, de Benoist B, Corigliano S, Jooste PL, Molinari L, Moosa K, et al. Assessment of iodine status using dried blood spot thyroglobulin: development of reference material and establishment of an international reference range in iodine-sufficient children. J Clin Endocrinol Metab. 2006;91:4881–7. doi: 10.1210/jc.2006-1370. [DOI] [PubMed] [Google Scholar]
  • 25.Van Herle AJ, Hershman JM, Hornabrook RW, Chopra IJ. Serum thyroglobulin in inhabitants of an endemic goiter region of New Guinea. J Clin Endocrinol Metab. 1976;43:512–6. doi: 10.1210/jcem-43-3-512. [DOI] [PubMed] [Google Scholar]
  • 26.Vermiglio F, Benvenga S, Melluso R, Catalfamo S, Princi P, Jr, Battiato S, et al. Increased serum thyroglobulin concentrations and impaired thyrotropin response to thyrotropin-releasing hormone in euthyroid subjects with endemic goiter in Sicily: their relation to goiter size and nodularity. J Endocrinol Invest. 1986;9:389–96. doi: 10.1007/BF03346949. [DOI] [PubMed] [Google Scholar]
  • 27.Pezzino V, Vigneri R, Squatrito S, Filetti S, Camus M, Polosa P. Increased serum thyroglobulin levels in patients with nontoxic goiter. J Clin Endocrinol Metab. 1978;46:653–7. doi: 10.1210/jcem-46-4-653. [DOI] [PubMed] [Google Scholar]
  • 28.Eltom M, Elmahdi EM, Salih MA, Mukhtar E, Omer MI. A new focus of endemic goitre in the Sudan. Trop Geogr Med. 1985;37:15–21. [PubMed] [Google Scholar]
  • 29.Hussein SI. IDD control in conflict zones: Sudan, Iraq and Afghanistan. IDD Newsletter. 2006;24:1–8. [Google Scholar]
  • 30.Kambal A. Endemic goiter in Darfur, Sudan [dissertation]. Khartoum: University of Khartoum; 1969. [Google Scholar]
  • 31.Moreno-Reyes R, Boelaert M, el Badawi S, Eltom M, Vanderpas JB. Endemic juvenile hypothyroidism in a severe endemic goitre area of Sudan. Clin Endocrinol (Oxf) 1993;38:19–24. doi: 10.1111/j.1365-2265.1993.tb00967.x. [DOI] [PubMed] [Google Scholar]
  • 32.Koutras DA. Endemic goiter–an update. Hormones (Athens) 2002;1:157–64. doi: 10.14310/horm.2002.1163. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES